Tag Archives: Amarin

[ad_1] Amarin Corporation plc (NASDAQ: AMRN) shares were falling Monday following the presentation of detailed primary results from the the late-stage REDUCE-IT study that evaluated Vascepa, held at a late-breaking session at …

[ad_1] Results from the 8,179-subject REDUCE-IT study evaluation Amarin's (NASDAQ: AMRN) Vascepa (icosapent ethyl) in statin-treated adults with elevated cardiovascular (CV) risk showed a significant treatment effect. The data were presented at …

[ad_1] Introduction I hope that everyone reading this has a baseline knowledge of Amarin (AMRN), its sole product Vascepa, and the REDUCE-IT cardiovascular outcomes trial, or CVOT. Further, presumably everyone is aware …

[ad_1] Amarin made waves in September, announcing her victory in the test-reduction of her purified fish oil product, Vascepa. The comprehensive data, presented yesterday at the meeting of the American Heart Association …

[ad_1] Recently, Amarin (AMRN) announced the results of its results study known as REDUCE-IT. The results of the test were very positive, as the main criterion was reached. This finding is important …

[ad_1] The biopharmaceutical company Amarin is doing the history of heart medicine Monday with its patented formulation of fish oil, called Vascepa. In a breathtaking clinical trial result that challenges years of …

[ad_1] The biopharmaceutical company Amarin is doing the history of heart medicine Monday with its patented formulation of fish oil, called Vascepa. In a breathtaking clinical trial result that challenges years of …

[ad_1] Amarin shares rose sharply on Monday, after the biopharmaceutical company's fish oil capsule showed tremendous benefits for cardiac patients in a clinical trial.

[ad_1] Amarin $ AMRN has claimed the next big hit in the cardio space, announcing an obvious statistical victory over the main criterion for its 7-year clinical research aimed at proving that …